本土创新降压药首方落地浦东,适用于九成以上高血压患者

上观新闻
Feb 10

本土原研创新降压药首方落地 采访对象提供今天,我国1类创新药——苹果酸司妥吉仑片,在上海市浦东新区公利医院开出首张处方。这款由上海医药集团股份有限公司研发、生产的新一代直接肾素抑制剂成功投入临床应用,标志着我国在高血压治疗创新药的研发生产上实现了“全链路贯通”,成为本土生物医药产业与临床诊疗深度融合的生动实践,这也是上海市生物医药先导产业创新发展取得的重要成果之一。上海医药中央研究院副院长夏广新...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10